Flu Vaccination Trial Launched at Local Pharmacies to Boost Access in Singapore

Singapore is taking a bold step in public healthcare by piloting a new initiative that allows residents to receive their annual influenza vaccinations at three selected retail pharmacies, starting from 28 October 2024. This trial aims to enhance access to flu jabs and make preventive healthcare more readily available.

Trial Locations and Details

  • Guardian Pharmacy at Nex Mall
  • Unity Pharmacy at Parkway Parade
  • Watsons Pharmacy at Paragon

These pharmacies have been thoroughly inspected to meet the Ministry of Health’s (MOH) stringent safety and operational requirements. Only trained pharmacists will be allowed to administer the vaccinations, ensuring a high standard of care.

Who Can Receive the Vaccination?

The vaccinations are available for all adults aged 18 and above, though those with specific medical conditions—such as a history of seizures or serious reactions to vaccines—are advised against participating. Pregnant women and those currently experiencing fever or respiratory infections should also refrain from getting the jab.

Costs and Subsidies

Eligible Singaporean citizens can enjoy government subsidies similar to those at Community Health Assist Scheme (CHAS) GP clinics, with a co-payment ranging between S$9 and S$35 depending on the pharmacy. To maintain an organised flow, individuals are encouraged to make appointments online, although walk-ins are also accepted.

Strengthening Preventive Healthcare

Health Minister Ong Ye Kung stressed the necessity of this initiative, noting that currently, only about 40 percent of seniors aged 65 and above are vaccinated against influenza. He highlighted that increasing vaccination coverage is crucial to reducing hospital admissions related to flu complications among the elderly.

With an ageing population, Mr Ong remarked, “Getting vaccinated can help prevent serious infections that lead to longer hospital stays or severe illnesses… It’s about making healthcare more accessible and integrated in the community.” A routine observation of 15 minutes post-vaccination will be conducted to manage any potential side effects.

Future Prospects

This initiative is part of a larger vision for healthcare in Singapore. The MOH plans to assess the success of the trial within the next three to six months, taking into account feedback and vaccination uptake. Additionally, there are plans for pharmacists to collaborate more closely with GPs in a team-based care model, which could include services like smoking cessation counselling and medication management.

In other countries, pharmacy-administered vaccinations are common. As Mr Ong noted, this move in Singapore could help to shift public perception and encourage more residents to get vaccinated, thereby supporting a healthier community.